
European Journal of Medicinal Chemistry p. 977 - 984 (1992)
Update date:2022-08-04
Topics:
Nicolaie, E
Guengoer, T
Goyard, J
Cure, G
Fouquet, A
et al.
The onset of diabetic complications may be prevented by the inhibition of aldose reductase.Derivatives of N-(quinolinyl thiocarbonyl) glycine were prepared and their in vitro and ex vivo aldose reductase inhibitory activities were tested on rat lens.The cincophen derivatives were the most potent in vitro with an enzyme inhibition value of 29percent at 10-8 M and 91percent at 10-7 for the N-<(2-phenylquinolin-4-yl)thiocarbonyl>-N-methylglycine compound 10a.This activity was shown to be dependent on the nature of the substituents and seems to be optimal for the acids; esterswerefound to be inactive.No compound have shown ex vivo inhibitory activity.It is concluded that the lack of ex vivo activity is likely due to a poor bioavailability or a bad penetration of the compounds in target tissue (lens). aldose reductase inhibitors / diabetic complications / N-(quinolinyl thiocarbonyl) glycine
View MoreContact:+86-18653358619
Address:zibo
ShanDong XinDa Chemical CO.,LTD(expird)
Contact:086-0311-87580543
Address:No.168, High Technology Development Zone Jinan Shandong China
Jinhua City Mingzhu Pharmaceutical Co.,Ltd.
Contact:15857995878 0579-82207761
Address:No.169 Shenze Road, New Area,Jinpan Development Zone, Jinhua
Contact:86-310-8067016
Address:East Fuhua Road,Tiexi Chemical Industrial Estate,Hebei,China
NANCHANG QINZHI SCI&TEC.CO.,LTD(expird)
Contact:+86-13687004106
Address:Hero South Road,Hero Zone,Nanchang,Jiangxi,China
Doi:10.3987/com-97-7949
(1998)Doi:10.1016/S0040-4039(00)91948-8
(1993)Doi:10.1007/s00044-013-0847-2
(2014)Doi:10.1016/j.tet.2013.10.062
(2013)Doi:10.1007/BF00472460
()Doi:10.1021/jo00934a008
(1974)